S&P launches emerging markets index
In response to the growing practice of investing in emerging markets, Standard & Poor’s (S&P) has launched a new index encompassing shares traded on the markets of Brazil, Russia, India and China.
The S&P BRIC 40 Index has been developed to provide exposure to 40 of the leading companies in the specified countries that are already trading on the market exchanges of Hong Kong, London, and New York (including the Nasdaq).
S&P managing director and index committee chair David Blitzer said the index had been established to alleviate investors’ concerns over the liquidity of the securities issued in the selected emerging markets.
“The construction of the S&P BRIC 40 Index accounts for both the liquidity of the underlying stocks as well as the liquidity of the overall portfolio, resulting in an index which is more efficient to invest in,” he explained.
The S&P BRIC 40 Index seeks to reflect available floats, enhance index basket liquidity, and lessen single stock concentration by employing a method where modifications are made to market cap weights.
All companies included in the index have met minimum market capitalisation and liquidity requirements, as governed by their S&P/IFCI index series memberships.
The launch of the index follows a similar move by Dow Jones earlier in the month.
Recommended for you
Having received bids from Bell Financial Group and AxiCorp, trading platform Selfwealth has confirmed it has entered into a scheme implementation deed after both parties were invited to make a higher bid.
Clime Investment Management has faced shareholder backlash around “unsatisfactory” financial results and is enacting cost reductions to return the business to profitability by Q1 2025.
Ausbil has expanded its distribution team with the hire of a manager for investment research and consulting, following the exit of its head of wholesale distribution in July.
Amid a growing appetite for alternatives, investment executives have shared questions advisers should consider when selecting a private markets product compared to their listed counterparts.
